Living Organ Donor Tax Credit Act of 2023

Treat and Reduce Obesity Act (H.R. 4818 / S. 4207) Home dialysis/home therapies issues Improving Access to Dialysis Act (H.R. 8075) Living Donor Protection Act (H.R. 2923/S. 1384) FY 2025 appropriations funding for nursing workforce development programs and National Institute of Nursing Research FY 2025 funding kidney disease research at NIDDK at NIH Funding for Kidney X program at HHS Funding for AHRQ at HHS in FY 2025 Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668) National Nursing Workforce Center Act (H.R. 2411/S. 1150) Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176) Living Donor Protection Act (H.R. 2923/S. 1384) Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027) Kidney Patient Access to Technology Innovative and Essential Nephrology Treatments (Kidney Patient) Act (H.R. 5074) Restore Protections for Dialysis Patients Act (H.R. 6860) Living Organ Donor Tax Credit Act (H.R. 6171) Honor Our Living Donors Act (H.R. 6020) Healthcare Workforce Resilience Act (H.R. 6205 / S. 3211) Restore Protections for Dialysis Patients Act (H.R. 6860) Future Advancement of Academic Nursing Act (H.R. 7266 / S. 3770) Organ Donation Referral Improvement Act (H.R. 9939)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases

Treat and Reduce Obesity Act (H.R. 4818 / S. 4207) Home dialysis/home therapies issues Improving Access to Dialysis Act (H.R. 8075) Living Donor Protection Act (H.R. 2923/S. 1384) FY 2025 appropriations funding for nursing workforce development programs and National Institute of Nursing Research FY 2025 funding kidney disease research at NIDDK at NIH Funding for Kidney X program at HHS Funding for AHRQ at HHS in FY 2025 Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668) National Nursing Workforce Center Act (H.R. 2411/S. 1150) Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176) Living Donor Protection Act (H.R. 2923/S. 1384) Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027) Kidney Patient Access to Technology Innovative and Essential Nephrology Treatments (Kidney Patient) Act (H.R. 5074) Restore Protections for Dialysis Patients Act (H.R. 6860) Living Organ Donor Tax Credit Act (H.R. 6171) Honor Our Living Donors Act (H.R. 6020) Healthcare Workforce Resilience Act (H.R. 6205 / S. 3211) Restore Protections for Dialysis Patients Act (H.R. 6860) Future Advancement of Academic Nursing Act (H.R. 7266 / S. 3770)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits. Prescription drug pricing and access.

Client expense: $80,000 · Firm income: Not reported

Home dialysis/home therapies issues Improving Access to Dialysis Act Living Donor Protection Act (H.R. 2923/S. 1384) FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research FY 2024 funding kidney disease research at NIDDK at NIH Funding for Kidney X program at HHS Funding for AHRQ at HHS Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668) National Nursing Workforce Center Act (H.R. 2411/S. 1150) Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176) Living Donor Protection Act (H.R. 2923/S. 1384) Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027) Kidney Patient Access to Technology Innovative and Essential Nephrology Treatments (Kidney Patient) Act (H.R. 5074) Restore Protections for Dialysis Patients Act (H.R. 6860) Living Organ Donor Tax Credit Act (H.R. 6171) Honor Our Living Donors Act (H.R. 6020) Healthcare Workforce Resilience Act (H.R. 6205 / S. 3211) Restore Protections for Dialysis Patients Act (H.R. 6860) Future Advancement of Academic Nursing Act (H.R. 7266 / S. 3770)

Client expense: Not reported · Firm income: $30,000

FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases

H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Comments to Organ Procurement and Transplantation Network regarding Kidney Donor Profile Index (KDPI) without race and HCV. Comments to OPTN regarding Contractor Board relationships. Comments to OPTN on proposed Expedited Placement Variance. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.

Client expense: $220,000 · Firm income: Not reported

Home dialysis/home therapies issues Improving Access to Dialysis Act Living Donor Protection Act (H.R. 2923/S. 1384) FY 2024 appropriations funding for nursing workforce development programs and National Institute of Nursing Research FY 2024 funding kidney disease research at NIDDK at NIH Funding for Kidney X program at HHS Funding for AHRQ at HHS Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544/S. 1668) National Nursing Workforce Center Act (H.R. 2411/S. 1150) Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2663/S. 1176) Living Donor Protection Act (H.R. 2923/S. 1384) Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027) Kidney Patient Access to Technology Innovative and Essential Nephrology Treatments (Kidney Patient) Act (H.R. 5074) Restore Protections for Dialysis Patients Act (H.R. 6860) Living Organ Donor Tax Credit Act (H.R. 6171) Honor Our Living Donors Act (H.R. 6020) Healthcare Workforce Resilience Act (H.R. 6205 / S. 3211)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases

Client expense: $50,000 · Firm income: Not reported

H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544, "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Activities to address chronic disease and metabolic disorders. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.

Client expense: $120,000 · Firm income: Not reported